Wilfred Daye
MD, Quant StrategiesPeerIQ
Part of the senior management team, Wilfred leads the quantitative strategy effort at PeerIQ, where his team focuses on building the best-in-class pricing, risk management, structuring and analytical capabilities. Prior to PeerIQ, Wilfred was a Structured Financing Trader for UBS, responsible for portfolio construction and risk management of securitized product collaterals. Before UBS, he was a senior counter-party risk quant for Deutsche Bank. Wilfred was a senior portfolio market risk manager for D.B. Zwirn, specializing in both cash and synthetic structured credit derivatives. Prior to his buy-side experience, he led Client Valuation Group for Lehman Brothers and was part of Risk Finance team at Barclays Capital. Wilfred began his career at Lehman Brothers, where we worked as an analyst for CMBS trading desk.

Wilfred earned his B.S. in Biochemistry from University of California and M.S. in Financial Engineering from Claremont Graduate School. He was a doctoral candidate in Pathology at USC School of Medicine. Wilfred holds FINRA Series 7, 63, and 24 licenses, and was awarded the CAIA designation from the Chartered Alternative Investment Analyst Association®.